Buyout bigs back $11bn orthopedic deal

Blackstone, Goldman Sachs, KKR and TPG have agreed to take private Biomet, a maker of replacement joints, alongside the company’s founder. At the same time, Biomet is investigating stock option back-dating practices approved by senior management.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this